Target intelligence / Profile preview

Immunoglobulin lambda variable 3-32 (non-functional) (IGLV3-32)

Target
IGLV3-32
Molecular classification
Immunoglobulin variable domain, Immunoglobulin light chain, Other
01

Overview

Immunoglobulin lambda variable 3-32 (IGLV3-32) is a variable region gene segment of the lambda light chain of immunoglobulins, classified as a probable non-functional open reading frame. This means that, although structurally a part of the immunoglobulin lambda locus, alterations at the DNA or protein level prevent it from producing a functional immunoglobulin light chain—either due to defective V-(D)-J recombination, splicing, or non-conserved amino acid changes. In functional immunoglobulins, the variable domains are critical for specific antigen recognition and immune response, forming part of the antigen-binding site together with the corresponding heavy chain's variable region. However, IGLV3-32 itself does not contribute to these immune functions because it is considered non-functional. Immunoglobulin variable regions as a family are central to adaptive immunity and antibody diversity, but IGLV3-32 does not encode for any productive or pathogenic immunoglobulin light chain, nor is it a drug target, receptor, or biomarker. It is, therefore, not considered a therapeutic target or a clinically actionable molecule.

Other names
Probable non-functional immunoglobulin lambda variable 3-32IGLV332V2-23PIGLV3-32
02

Biological functions

Immune response (predicted/putative)Antigen binding (in context of functional immunoglobulins; this isoform is non-functional)
03

Disease associations

Other (no direct disease role due to non-functionality; immunoglobulin genes in general are involved in various immune diseases, but this allele is non-functional)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 3-32 (non-functional) (IGLV3-32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 3-32 (non-functional) (IGLV3-32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call